Investing In Elevance Health Inc (NYSE: ELV): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Elevance Health Announces Closing of Paragon Healthcare Acquisition.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NYSE and operates within the Healthcare Plans industry segment. The current market capitalization of Elevance Health Inc is $118.54B. A total of 0.92 million shares were traded on the day, compared to an average of 1.08M shares.

In the most recent transaction, Kendrick Charles Morgan JR sold 2,432 shares of ELV for 500.46 per share on Mar 08 ’24. After the transaction, the EVP & President, Commercial now owns 15,840 company shares. In a previous transaction on Mar 06 ’24, Penczek Ronald W sold 916 shares at 504.58 per share. ELV shares that CAO & Controller owns now total 1,764.

Among the insiders who sold shares, Haytaian Peter D disposed of 21,095 shares on Mar 04 ’24 at a per-share price of $500.18. This resulted in the EVP & Pres Carelon & CarelonRx holding 18,887 shares of ELV after the transaction. In another insider transaction, PERU RAMIRO G sold 753 shares at $500.00 per share on Feb 07 ’24. Company shares held by the Director now total 9,109.

Dividend

The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Elevance Health Inc pays an annual dividend of $6.07, resulting in a dividend yield of 1.19%, and it has a price to earnings (P/E) ratio of 20.24. ELV’s most recent ex-dividend date was 3/7/2024 when it declared a $1.63 quarterly dividend that was paid in cash on 3/22/2024. Previously, the company paid the dividend on 12/21/2023 with an ex-dividend date of 12/5/2023. The ELV stock dividend was $1.48 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ELV has a high of $516.61 and a low of $412.00.

As of this writing, ELV has an earnings estimate of $10.45 per share for the current quarter. EPS was calculated based on a consensus of 16 estimates, with a high estimate of $10.83 per share and a lower estimate of $10.04. The company reported an EPS of $8.99 in the last quarter, which was 6.50% higher than expectations of $8.44.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ELV’s latest balance sheet shows that the firm has $31.15B in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $168.64, while its Total Shareholder’s Equity was $36.13B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELV is Buy with a score of 4.81.

Most Popular

Related Posts